Back to Health
The Clinical Trial Vanguard·

Digoxin’s Second Chance Just Ran Out: What a Failed Phase 3 RCT Reveals About Cardiovascular Drug Development

Digoxin’s Second Chance Just Ran Out: What a Failed Phase 3 RCT Reveals About Cardiovascular Drug Development

Low-dose digoxin cut hospitalizations but missed its primary endpoint in a 1,400-patient RCT—exposing a gap between statistical significance and regulatory…

You are reading a snippet

Read the full article on The Clinical Trial Vanguard

Open on The Clinical Trial Vanguard

Originally published by The Clinical Trial Vanguard

More from Health

Uganda’s inhaler gap leaves asthma patients exposed
The Independent Uganda13h ago

Uganda’s inhaler gap leaves asthma patients exposed

Asthma is responsible for more than 450,000 deaths globally every year, many of which are preventable   Kampala, Uganda | PATRICIA AKANKWATSA | Uganda’s response to asthma is facing growing scrutiny as health specialists warn that thousands of patients are still unable to access essential inhalers,…

5 tips to help you poop better
NPR13h ago

5 tips to help you poop better

Think you know how to go No. 2? Think again. Dr. Trisha Pasricha, author of the new book You’ve Been Pooping All Wrong: How to Make Your Bowel Movements a Joy, shares common bathroom practices she wishes would go away — like holding your poop — and tips on how to reduce strain on the toilet.Follow…

One American tests positive for hantavirus after cruise
TimesLIVE13h ago

One American tests positive for hantavirus after cruise

US citizen on cruise has tested positive for hantavirus, another has mild symptoms

Hantavirus: American passenger evacuated from MV Hondius cruise ship tests positive
The Hindu14h ago

Hantavirus: American passenger evacuated from MV Hondius cruise ship tests positive

Evacuated passengers from a hantavirus-affected cruise ship face health monitoring after one tests positive and another shows symptoms.